Combining Machine Learning (ML) with Flow Cytometry Based Immunophenotyping: a Novel Liquid Biopsy Aid for Identifying the Risk for Prostate Cancer (PCa)

Poster

Using Machine Learning to Predict the Risk of Either Having an Aggressive Form of Prostate Cancer (PCa) or Lower Grade PCa/Benign Prostatic Hyperplasia (BPH) Based Upon the Flow Cytometry Immunophenotyping of Myeloid-derived Suppressor Cells (MDSCs) and Lymphocyte Cell Populations

Presentation

Combining Immunophenotyping and Artificial Intelligence for Early Cancer Detection

Presentation

Combining the Immunophenotyping of MDSCs and Lymphocytes with Artificial Intelligence (AI) to Predict Early Stage Breast Cancer

Poster

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

Read More...

Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

Read More...

Anixa Biosciences to Present at the CYTO 2019 - 34th Congress of the International Society for Advancement of Cytometry

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.